CTRI/2023/01/048849
Completed
未知
A retrospective study to evaluate efficacy and safety of oral tofacitinib in vitiligo and its variants
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- A
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All clinically diagnosed cases of different variants of vitiligo
- •2\.Patients who were started on oral tofacitinib for vitiligo
Exclusion Criteria
- •Patients receiving other systemic immunosuppressive drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effectiveness of Covid-19 vaccination and incidence of SARS-COV-2 reinfection in healthcare and frontline workers working in a tertiary cancer centre of India.CTRI/2021/08/035655Tata Memorial Centre
Recruiting
Not Applicable
A retrospective study to evaluate the efficacy and safety of carbon ion radiation therapy for primary lung cancer.primary lung cancerJPRN-UMIN000052389ational institutes for Quatum Science and Technology150
Not yet recruiting
Not Applicable
Affects of Tapentadol nasal spray in back acheHealth Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueCTRI/2024/05/067264Dr Shobhan Mandal
Recruiting
Not Applicable
A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim* System for the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System study)Overactive bladderfrequent need to urinate10004994NL-OMON55598BlueWind Medical Ltd.25
Completed
Phase 2
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastasescastration-resistant prostate cancer with bone metastasesJPRN-UMIN000023897ational Hospital Organization Saitama Hospital20